New MGA Report on a Medicare Shared Savings Demonstration for Biosimilars

Matrix Global Advisors (MGA) today released a new report, “Shared Savings Demonstration for Biosimilars in Medicare: An Opportunity to Promote Biologic Drug Competition,” by MGA founder and CEO Alex Brill. The report identifies a unique opportunity in Medicare Part B to boost biosimilar utilization through the establishment of a shared savings demonstration model administered by the Centers for Medicare & Medicaid Services Innovation Center.

MGA’s Alex Brill on CNBC’s Squawk Box

“We want the program to work and I think that sadly what we’re seeing is that the program is working quite well. And I say sadly because we are seeing tens of millions of people process through that system and we’re going to continue to see that I think for the next few weeks as the backlogs in certain states get worked through…”

New Analysis Situates COVID-19 Alongside 1918 Pandemic, Predicts 12 Million–26 Million Hospitalizations

A new report released today by Matrix Global Advisors (MGA) finds that COVID-19 is likely as severe as the 1918 pandemic, the worst pandemic in the twentieth century. MGA evaluated COVID-19 data using the Centers for Disease Control and Prevention’s Pandemic Severity Assessment Framework (PSAF) and found that the current pandemic’s clinical severity (how sick the virus makes people) and transmissibility (how contagious the virus is) are the highest measurable by that tool.

Efforts to Combat E-Cigarette Misuse Could Backfire

Recent news about e-cigarette misuse has fueled both public misperception and policy responses that are likely to have unintended consequences. As the US vaping market continues to evolve, policymakers face the tricky challenge of safeguarding the potential for positive public health outcomes from e-cigarettes, which offer a lower-risk alternative to traditional cigarettes, while ensuring reasonable protections against youth use.